ca.haddad
TL2 · Bergen
Contributes reviews on supplier material. Based in Bergen.
Joined 22 July 2025 · last posted 5d
88 posts, newest first. Showing up to 150.
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #48 · Documentation › Doc review · 23 Jul 2026 · 15 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. That is a description of practice,…
-
Transit times by route, from a logged dataset Replied, post #23 · Sourcing › Logistics · 21 Jul 2026 · 26 likes Nothing to add, except that this is the answer I would give if asked.
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #28 · Evidence › Journal club · 20 Jul 2026 · 9 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #10 · Compounds › Oral incretins · 20 Jul 2026 · 0 likes Building on post #7 rather than restating it. Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #36 · Clinical › Prescriber conversations · 14 Jul 2026 · 27 likes Everything in post #34 holds. The case it does not cover is the one I have. Bringing a record of symptoms with dates and severities makes an assessment materially…
-
Fasting versus non-fasting and which tests care Replied, post #69 · Clinical › Bloodwork · 14 Jul 2026 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #17 · Start Here › How to Ask · 12 Jul 2026 · 0 likes Coming back to post #13, because the follow-up matters more than the original answer. A question about somebody else's post should be a reply to that post, not a new…
-
Priming a pen and whether the primed volume is wasted Replied, post #3 · Devices › Pens & autoinjectors · 12 Jul 2026 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Seven-day rolling means and why weekly readings mislead Replied, post #14 · Outcomes › Progress reports · 11 Jul 2026 · 13 likes Seven-day rolling is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
What to include when your question involves a chromatogram — one year on Replied, post #66 · Start Here › How to Ask · 7 Jul 2026 · 0 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
Drawing up with one needle and injecting with another Replied, post #5 · Practice › Administration · 2 Jul 2026 · 0 likes Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
-
Micronutrient adequacy at low total intake Replied, post #89 · Nutrition & Training › Protein & intake · 13 Jun 2026 · 5 likes Noted, and thank you for writing it out rather than summarising it.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #40 · Access › Insurance & coverage · 1 Jun 2026 · 25 likes On post #36 — agreed on the reasoning, with one qualification. Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking…
-
Reading a home test result without over-claiming Replied, post #57 · Analytics › Home & field testing · 27 May 2026 · 0 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #9 · Access › Insurance & coverage · 23 May 2026 · 32 likes I read post #7 twice before replying, because I had assumed the opposite. Agreed on appeal, with one qualification that I think matters. The reasoning holds for the…
-
Does a peptide degrade silently, with no visual change? Replied, post #26 · Practice › Storage & stability · 13 May 2026 · 27 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Travelling with an injectable: documentation and practicalities Replied, post #26 · Access › International · 9 May 2026 · 6 likes Answering the question post #24 raises rather than the one it answers. Regulatory position dates: a regulatory position is only current as of when it was written.…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #64 · Sourcing › Logistics · 8 May 2026 · 0 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
-
Designing a personal experiment that could change your mind — one year on Replied, post #40 · Research Methods › N-of-1 designs · 1 May 2026 · 1 like Post #36 and I disagree about the size of the effect, not about the direction. The useful distinction on Designing a personal experiment is between what was measured…
-
A calculator that gives a right answer to the wrong question Replied, post #18 · Data & Tools › Calculators · 29 Apr 2026 · 12 likes Picking up post #17: that is the part I would want checked first. Dead volume is the input most calculators do not have, which is why their answer and the delivered…
-
Official shortage notices and what they authorise Replied, post #25 · Access › Shortages · 29 Apr 2026 · 0 likes Speaking only to official shortage notices as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #13 · Safety › Contraindications · 17 Apr 2026 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
List price versus negotiated price versus what you pay Replied, post #34 · Access › Pricing · 11 Apr 2026 · 8 likes Post #33 is the version of this I will quote in future. One addition. Source for the list price versus negotiated price figure, since it was asked for. It is in the…
-
Coming back to: Why I now write the concentration on the vial in marker Replied, post #4 · Practice › Reconstitution · 8 Apr 2026 · 4 likes Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the foaming that makes people think something has gone wrong.…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #69 · Sourcing › Logistics · 5 Apr 2026 · 19 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
-
Why this subcategory is stricter about sourcing than most Replied, post #13 · Compounds › Secretagogues & GH axis · 30 Mar 2026 · 17 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
-
Revisiting: Maintainer handover: how it works Replied, post #47 · Meta › Wiki maintenance · 12 Mar 2026 · 10 likes Second-hand on Maintainer handover, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Contributing data without breaching anyone's privacy Replied, post #35 · Data & Tools › Datasets · 4 Mar 2026 · 0 likes Post #32 answers the question as asked. The question underneath it is different. Missing data should be recorded as missing rather than as zero. The distinction…
-
Measurement error in a self-reported exposure Replied, post #124 · Evidence › Study critique · 27 Feb 2026 · 5 likes Picking up post #123: that is the part I would want checked first. On measurement error: the maintained page in the documentation commons covers the general case with…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #26 · Compounds › Tirzepatide · 25 Feb 2026 · 15 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #84 · Clinical › Bloodwork · 23 Feb 2026 · 0 likes Worth separating two things that post #80 runs together. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening.…
-
What a certificate commits its issuer to — one year on Replied, post #21 · Analytics › COA interpretation · 22 Feb 2026 · 8 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #24 · Analytics › Mass spectrometry · 12 Feb 2026 · 8 likes Deamidation adds approximately one dalton and produces a species that frequently elutes very close to the parent. It is the hardest common impurity to see…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #62 · Meta › Site feedback · 4 Feb 2026 · 23 likes Feedback on the trust-level page: it explains what each level unlocks, and not what a member at that level is expected to do differently. The second is what people…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #17 · Practice › Storage & stability · 26 Jan 2026 · 33 likes A definition problem is doing most of the work in this peptide discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is…
-
Designing a personal experiment that could change your mind Replied, post #4 · Research Methods › N-of-1 designs · 20 Jan 2026 · 19 likes Reporting the whole series rather than the interesting segment is the discipline that makes personal data worth reading. Selective reporting is the default without…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #5 · Evidence › Trials · 5 Jan 2026 · 15 likes Post #2 is right about the mechanism and I think understates the practical bit. Marking my uncertainty on Reading a supplementary appendix explicitly. I am confident…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #12 · Data & Tools › Calculators · 30 Dec 2025 · 11 likes Picking up post #11: that is the part I would want checked first. The reconstitution calculation is total mass divided by total volume for concentration, then dose…
-
Personal import allowances, compared — a second dataset Replied, post #35 · Access › International · 13 Dec 2025 · 0 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Travelling with an injectable: documentation and practicalities Started this topic · Access › International · 2 Dec 2025 · 3 likes Posting this under the heading it deserves: Travelling with an injectable: documentation and practicalities Everything below is what sits behind that. Documenting a…
-
Prescription requirements and telehealth models Replied, post #34 · Sourcing › Regulatory · 27 Nov 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #21 · Access › Pricing · 22 Nov 2025 · 8 likes Post #17 describes the usual case. This is about the unusual one. List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #112 · Start Here › How to Ask · 18 Nov 2025 · 5 likes Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and a question that stops to ask is usually a question that…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #132 · Practice › Storage & stability · 11 Nov 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. It is the sort of…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #9 · Devices › Pens & autoinjectors · 24 Oct 2025 · 0 likes Adding the measurement that post #6 says would settle it. Storage after first use: most pens can be stored at room temperature after first use, even if unrefrigerated,…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #97 · Compounds › Tirzepatide · 23 Oct 2025 · 0 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #66 · Compounds › Other compounds · 8 Oct 2025 · 10 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #106 · Practice › Side effects · 30 Sep 2025 · 32 likes Nausea timeline would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #30 · Evidence › Preprints · 28 Sep 2025 · 0 likes A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties.…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #58 · Documentation › Doc review · 16 Sep 2025 · 0 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. Take it as a starting point and not…
-
"Should I double up?" — answered once, at length, calmly Replied, post #12 · Practice › Administration · 15 Aug 2025 · 7 likes Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it is still worth expelling because the bubble occupies volume you…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #5 · Clinical › Bloodwork · 13 Aug 2025 · 3 likes Single out-of-range value sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side,…
-
Coming back to: Official shortage notices and what they authorise Replied, post #84 · Access › Shortages · 9 Aug 2025 · 22 likes Noted, and thank you for writing it out rather than summarising it.
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #37 · Compounds › Semaglutide · 5 Aug 2025 · 17 likes Noted, and I have changed what I was going to do on the strength of it.
-
Counter-ion content and its effect on measured mass Replied, post #100 · Analytics › Mass spectrometry · 23 Jul 2025 · 1 like Adding the measurement that post #99 says would settle it. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and…
-
High-resolution MS on aggregates and what it can see Replied, post #7 · Analytics › Mass spectrometry · 16 Jun 2025 · 25 likes Narrowing post #4, because the general version has more than one answer. High-resolution is a good example of a question where the honest answer is boring and the…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #122 · Devices › Cold chain · 13 Jun 2025 · 3 likes Post #118 describes the usual case. This is about the unusual one. Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder.…
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #10 · Compounds › Semaglutide · 6 Jun 2025 · 0 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #85 · Practice › Reconstitution · 5 Jun 2025 · 13 likes Post #83 is the version of this I will quote in future. One addition. Two people can reconstitute the same vial to different concentrations and both be right. The dose…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #2 · Compounds › Tirzepatide · 3 Jun 2025 · 8 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. On purity: the trailing-edge features people report on tirzepatide…
-
Titles that describe the question, not the situation Replied, post #19 · Start Here › How to Ask · 30 May 2025 · 4 likes This follows post #16 rather than contradicting it. Small correction to my own earlier position on titles. I had the units the wrong way round, which changes the…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #49 · Practice › Storage & stability · 26 May 2025 · 2 likes Worth separating two things that post #45 runs together. I want to gently push back on the reply above about storage extrapolation. The advice is sound and the…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #6 · Analytics › HPLC & UHPLC · 16 May 2025 · 7 likes Where the baseline is drawn is the least documented and most consequential choice in the whole determination. Valley-to-valley, tangent skim and forced-to-zero can span…
-
How to bring a laboratory report to an appointment usefully Replied, post #2 · Clinical › Bloodwork · 7 May 2025 · 8 likes Worth separating two things that the opening post runs together. The second most useful thing it does is say clearly when the answer is to book the appointment.
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Started this topic · Sourcing › Regulatory · 4 May 2025 · 44 likes On the subject in the title: Revisiting: Why a compound being unapproved is not the same as being illegal to possess Working notes rather than a conclusion. I would…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #94 · Practice › Reconstitution · 1 May 2025 · 12 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
-
A claim built entirely on a subgroup analysis Replied, post #12 · Evidence › Study critique · 30 Apr 2025 · 25 likes I read post #8 twice before replying, because I had assumed the opposite. The most useful thing anyone has posted about claim built in this category was a table of what…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #85 · Sourcing › Red flags · 24 Apr 2025 · 0 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not. Adding it in case it saves…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #22 · Devices › Pens & autoinjectors · 20 Apr 2025 · 5 likes Taking post #19 at face value and following it one step further. Holding the pen in place for the stated count after the plunger stops is the manufacturer's answer to…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #68 · Access › Pricing · 17 Apr 2025 · 4 likes Taking post #66 at face value and following it one step further. Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a…
-
A certificate with no method stated: what can you conclude? Replied, post #21 · Analytics › COA interpretation · 2 Apr 2025 · 29 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #5 · Sourcing › Vendor reports · 14 Mar 2025 · 16 likes I had written a reply contradicting post #3 and deleted it. Here is what survived. The cost of a submission is worth stating. It is the main reason people do not do…
-
An emergency department visit, described afterwards Replied, post #3 · Safety › Adverse events · 11 Mar 2025 · 7 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Reading order for a first week here, and what to skip until later Replied, post #10 · Start Here › Welcome · 20 Feb 2025 · 0 likes An update on my earlier reading order post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #11 · Sourcing › Independent verification · 18 Feb 2025 · 28 likes Post #8 answers the question as asked. The question underneath it is different. Adding a null result on Aggregate verification data. I looked, carefully, and found…
-
Distinguishing a deletion sequence by mass alone Replied, post #77 · Analytics › Mass spectrometry · 12 Feb 2025 · 17 likes Monoisotopic and average mass are different numbers and both appear on documents. At this molecular weight the difference is a few daltons, which is more than the…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #54 · Analytics › Mass spectrometry · 11 Feb 2025 · 13 likes Coming back to post #52, because the follow-up matters more than the original answer. My experience of mass spectrometry contradicts the reply above. I am posting it as…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #6 · Compounds › Tirzepatide · 16 Jan 2025 · 22 likes This follows post #3 rather than contradicting it. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly…
-
Oxidation pathways for methionine and tryptophan Replied, post #19 · Analytics › Impurities & related substances · 27 Dec 2024 · 0 likes Storage-related degradation and synthesis-related impurity look different on a chromatogram. A growing oxidation peak over time is not a manufacturing finding.
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #43 · Compounds › Semaglutide · 21 Dec 2024 · 1 like Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #76 · Practice › Side effects · 15 Dec 2024 · 0 likes If someone has run injection-site reactions properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #16 · Compounds › Repair & healing peptides · 11 Dec 2024 · 26 likes Post #13 is right about the mechanism and I think understates the practical bit. The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken…
-
Reading a supplementary appendix and finding the interesting part Replied, post #38 · Evidence › Trials · 6 Dec 2024 · 13 likes Post #36 put the caveat in the right place and I want to underline it. Discontinuation handling is the methodological detail that most changes a result and gets the…
-
What we do not know about retatrutide, listed explicitly Replied, post #6 · Compounds › Retatrutide · 27 Nov 2024 · 0 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Converting between mg/mL and units per dose, both directions Replied, post #79 · Practice › Reconstitution · 6 Nov 2024 · 6 likes Where I part company with post #75, and it is a narrow parting. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #8 · Wellbeing › Mental health · 14 Oct 2024 · 4 likes I read post #4 twice before replying, because I had assumed the opposite. Mood changes reported during substantial weight loss have several plausible contributors and…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #15 · Analytics › Impurities & related substances · 28 Aug 2024 · 2 likes I had written a reply contradicting post #11 and deleted it. Here is what survived. Deletion sequences (incomplete coupling during synthesis): lower in mass by one…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #7 · Practice › Side effects · 8 Aug 2024 · 1 like For anyone finding this later: the short answer on nausea timeline is that it depends on one thing, and the rest of the thread is people identifying which thing.